
Chinese General Practice ›› 2018, Vol. 21 ›› Issue (25): 3133-3138.DOI: 10.12114/j.issn.1007-9572.2018.00.073
• Monographic Research • Previous Articles Next Articles
Published:2018-09-05
Online:2018-09-05
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2018.00.073
| [1]ARROYO-JOHNSON C,MINCEY K D.Obesity epidemiology worldwide[J].Gastroenterol Clin North Am,2016,45(4):571-579.DOI:10.1016/j.gtc.2016.07.012.3137 [2]RODRIGUES A M,GREGóRIO M J,SOUSA R D,et al.Challenges of ageing in Portugal:data from the EpiDoC cohort[J].Acta Med Port,2018,31(2):80-93.DOI:10.20344/amp.9817.3137 [3]YANDRAPALLI S,PAL S,NABORS C,et al.Drug treatment of hypertension in older patients with diabetes mellitus[J]. Expert Opin Pharmacother,2018,26:1-10.DOI:10.1080/14656566.2018.1456529.3137 [4]NAKAMURA K,OKAMURA T,KANDA H,et al.Medical costs of patients with hypertension and/or diabetes:a 10-year follow-up study of National Health Insurance in Shiga,Japan[J].Journal of Hypertension,2006,24(11):2305-2309.DOI:10.1097/01.hjh.0000249711.28769.80.3137 [5]厦门市卫生计生委.关于全面推进高血压病、糖尿病“三师共管”分级诊疗试点改革工作实施方案(试行)的通知[Z].2015.3137 [6]中国高血压防治指南修订委员会.中国高血压防治指南[J].中华高血压杂志,2011,19(8):701-743.DOI:10.16439/j.cnki.1673-7245.2011.08.009.3137 Revision Committee of China's Guidelines for the Prevention and Treatment of Hypertension.Guidelines for the prevention and treatment of hypertension in China [J].Chinese Journal of Hypertension,2011,19(8):701-743.DOI:10.16439/j.cnki.1673-7245.2011.08.009.3137 [7]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.DOI:10.3760/cma.j.issn.1674-5809.2018.01.003.3137 Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China(2017 edition)[J].Chinese Journal of Diabetes Mellitus,2018,10(1):4-67.DOI:10.3760/cma.j.issn.1674-5809.2018.01.003.3137 [8]中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.DOI:10.3969/j.issn.1000-3614.2016.10.001.3137 Chinese Adult Dyslipidemia Prevention Guidelines Revision Joint Committee.Guidelines for the prevention and treatment of dyslipidemia in adults in China(revised version 2016)[J]. Chinese Circulation Journal,2016,31(10):937-953.DOI:10.3969/j.issn.1000-3614.2016.10.001.3137 [9]葛文亮.尿微量白蛋白对糖尿病肾病的早期诊断价值[J].放射免疫学杂志,2004,17(4):285.DOI:10.3969/j.issn.1008-9810.2004.04.022.3137 GE W L.The early diagnostic value of microalbuminuria in diabetic nephropathy[J].Journal of Radioimmunology,2004,17(4):285.DOI:10.3969/j.issn.1008-9810.2004.04.022.3137 [10]张霞,孟静,罗伟.新诊断妊娠期糖尿病患者检测尿微量白蛋白的临床意义[J].中国优生与遗传杂志,2007,15(10):42.DOI:10.13404/j.cnki.cjbhh.2007.10.029.3137 ZHANG X,MENG J,LUO W.The clinical significance of measuring of urine microalbumin in gestational diabetes mellitus patients with new diagonosis[J].Chinese Journal of Birth Health & Heredity,2007,15(10):42.DOI:10.13404/j.cnki.cjbhh.2007.10.029.3137 [11]WANG J,ZHANG L,WANG F,et al.Prevalence,awareness,treatment,and control of hypertension in China:results from a national survey[J].American Journal of Hypertension,2014,27(11):1355-1361.DOI:10.1093/ajh/hpu053.3138 [12]LIN K,PARK C,LI M,et al.Effects of depression,diabetes distress,diabetes self-efficacy,and diabetes self-management on glycemic control among Chinese population with type 2 diabetes mellitus[J].Diabetes Research and Clinical Practice,2017,131(179):179-186.DOI:10.1016/j.diabres.2017.03.013.3138 [13]GRAY R S,FABSITZ R R,COWAN L D,et al.Risk factor clustering in the insulin resistance syndrome[J].American Journal of Epidemiology,1998,148(9):869-878.3138 [14]FAIN J.Correlative studies on the effects of obesity,diabetes and hypertension on gene expression in omental adipose tissue of obese women[J].Nutrition and Diabetes,2011,1(9):10.DOI:10.1038/nutd.2011.14.3138 [15]许培培,张琳,向全永,等.我国功能社区高血压防治现状及规范化管理关键技术研究进展[J].中国临床研究,2016,29 (9):1293-1296.DOI:10.13429/j.cnki.cjcr.2016.09.046.3138 XU P P,ZHANG L,XIANG Q Y,et al.The current situation of the community based hypertention prevention and treatment,and the development of the key technology of standardized management of hypertention in our country[J].Chinese Journal of Clinical Research,2016,29(9):1293-1296.DOI:10.13429/j.cnki.cjcr.2016.09.046.3138 [16]陈伟伟,高润霖,刘力生,等.《中国心血管病报告 2014》概要[J].中国循环杂志,2015,30(7):617-622.DOI:10.3969/j.issn.1000-3614.2015.07.001.3138 CHEN W W,GAO R L,LIU L S,et al.A summary of China cardiovascular disease report 2014[J].Chinese Circulation Journal,2015,30(7):617-622.DOI:10.3969/j.issn.1000-3614.2015.07.001.3138 [17]邹文淑,高玲,罗雪,等.老年高血压伴葡萄糖耐量异常的治疗[J].中国老年学杂志,2010,30(22):3406-3407.DOI:10.3969/j.issn.1005-9202.2010.22.088.3138 ZOU W S,GAO L,LUO X,et al.The treatment of elderly hypertensive patients with lmpaired glucose tolerance[J].Chinese Journal of Gerontology,2010,30(22):3406-3407.DOI:10.3969/j.issn.1005-9202.2010.22.088.3138 [18]CHEUNG B M.The hypertension-diabetes continuum[J].J Cardiovasc pharmacol,2010,55(4):333-339.DOI:10.1097/FJC.0b013e3181d26430.3138 [19]GRESS T W,NIETO F J,SHAHAR E,et al.Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus.Atherosclerosis risk in communities study[J].New England Journal of Medicine,2000,342(13):905-912.DOI:10.1056/NEJM200003303421301.3138 [20]COSENTINO F,PANENI F,COSTANTINO S.Diabetes and hypertension:are they two diseases of the endothelium[J]. Dialogues in Cardiovascular Medicine,2016,21(2):113-123.3138 [21]朱责梅,杨丝丝,伍迪,等. 胰岛素抵抗与糖尿病脑病[J].生理科学进展,2016,47(5):395-400.3138 ZHU Z M,YANG S S,WU D,et al.Insulin resistance and diabetic encephalopathy[J].Progress in Physiological Sciences,2016,47(5):395-400.3138 [22]KEK?L?INEN P,SARLUND H,LAAKSO M.Long-term association of cardiovascular risk factors with impaired insulin secretion and insulin resistance[J].Metabolism,2000,49(10):1247-1254.DOI:10.1053/meta.2000.9514.3138 [23]DONNENFELD S,WEBER S,BEN-ZION U.Familial(shared environmental and genetic)factors and the foetal origins of cardiovascular diseases and type 2 diabetes:a review of the literature[J].J Intern Med,2008,264(3):205-223.DOI:10.1016/0022-1996(85)90041-8.3138 [24]SESSO H D,BURING J E,RIFAI N,et al.C-reactive protein and the risk of developing hypertension[J]. JAMA,2003,290(22):2945-2951.DOI:10.1001/jama.290.22.2945.3138 [25]FURIE K L,KASNER S E,ADAMS R J,等.卒中或短暂性脑缺血发作患者的卒中预防指南美国心脏协会/美国卒中协会为医疗卫生专业人员制定的指南[J].国际脑血管病杂志,2011,19(1):1-49.DOI:10.3760/cma.j.issn.1673-4165.2011.01.001.3138 FURIE K L,KASNER S E,ADAMS R J,et al.Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack——a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].International Journal of Cerebrovascular Diseases,2011,19(1):1-49.DOI:10.3760/cma.j.issn.1673-4165.2011.01.001.3138 [26]ZHU C H,ZHANG S S,KONG Y,et al. Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with typeⅡ diabetes mellitus[J]. Int J Ophthalmol,2013,6(2):141-145.DOI:10.3980/j.issn.2222-3959.2013.02.06.3138 [27]WEIR M R.Microalbuminuria and cardiovascular disease[J]. Clin J Am Soc Nephrol,2007,2(3):581-590.DOI:10.2215/CJN.03190906.3138 [28]赵珈艺,张志辰,金香兰,等.北京市丰台区部分社区脑卒中高危人群血脂控制现状调查及中医症状证候分析[J]. 世界中医药,2016,11(1):40-44.DOI:10.3969/j.issn.1673-7202.2016.01.009.3138 ZHAO J Y,ZHANG Z C,JIN X L,et al.Observation on blood lipids control of high risk population of stroke and its TCM syndrome in Fengtai Community[J].World Chinese Medicine,2016,11 (1):40-44.DOI:10.3969/j.issn.1673-7202.2016.01.009.3138 [29]袁莎莎,王芳,李陈晨,等.完善社区卫生服务模式的保障机制分析[J]. 中国卫生政策研究,2014,7(12):43-49.DOI:10.3969/j.issn.1674-2982.2014.12.008.3138 YUAN S S,WANG F,LI C C,et al.Analysis on guarantee mechanisms related to the improvement of community health service modes[J]. Chinese Journal of Health Policy,2014,7(12):43-49.DOI:10.3969/j.issn.1674-2982.2014.12.008.3138 |
| [1] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
| [2] | BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746. |
| [3] | QIN Bangguo, SUN Jin, LI Man, QIU Jiaojiao, CHENG Bokai, ZHU Ping, WANG Shuxia. Relationship between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Left Ventricular Hypertrophy in a Community-based Hypertensive Population [J]. Chinese General Practice, 2025, 28(30): 3753-3760. |
| [4] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
| [5] | ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313. |
| [6] | HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258. |
| [7] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
| [8] | TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103. |
| [9] | TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua. Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3089-3095. |
| [10] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
| [11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
| [12] | WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan. Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension [J]. Chinese General Practice, 2025, 28(24): 2972-2978. |
| [13] | HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971. |
| [14] | LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin. Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2852-2860. |
| [15] | WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei. Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(23): 2846-2851. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||